Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Statement of Deviation or Variation, along with Certificate issued by Statutory Auditor in respect of the utilization of the proceeds of the Preferential Issue of Warrants of the Company as on period ended December 31, 2025.
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 31.12.2025
View original source (BSE India)Trident Texofab Ltd. on 6ix
Earlier from Trident Texofab
- Result- Financial Result Of The Quarter And Nine Months Ended 31St December, 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On February 12, 2026
- Trident Texofab Ltd. Press Release Feb 06 2026
- Board Meeting Intimation for Consideration And Approval Of Un-Audited Fincnail Result For The Quarter Ended 31.12.2025
- Trident Texofab Ltd. Press Release Jan 07 2026
Later from Trident Texofab
- Outcome of the separate meeting of independent directors of the company held on 27.03.2026
- Trident Texofab Ltd. Press Release Mar 27 2026
- Closure of Trading Window
- Trident Texofab Ltd. Press Release Mar 30 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab